Spatial Genomics
PrivateLast Round
Series A
Feb 23, 2022
Total Funding Raised
$56.92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spatial Genomics operates in Healthcare & Life Sciences and is based in Pasadena, California. Its latest recorded funding round was a Series A round in February 2022.
Spatial Genomics is a biotechnology company that develops a spatial single-cell multiomics analysis platform based on seqFISH technology to map gene expression and cellular interactions within tissue microenvironments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Data Visualization, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spatial Genomics Comparables
Compare Spatial Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resolve Biosciences | 86% | |
| Stellaromics | 84% | |
| Vizgen | 82% |
For institutional investors. Book with your work email.
Spatial Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 23, 2022 | ||||
| Grant | Oct 28, 2020 | ||||
| Grant | Jun 21, 2019 | ||||
| Grant | Jul 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Spatial Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| National Cancer Institute | Grant |
| National Institute on Aging | Grant |
| Chan Zuckerberg Initiative | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 79% MoM, reaching 3K.
- Jun 24, 2026
Monthly visitors increased 64% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- files_suit_againstAug 7, 2026
Spatial Genomics, Inc. and the California Institute of Technology file a lawsuit against 10x Genomics, Inc., alleging that its Xenium spatial biology platform infringes their patents, as 10x Genomics, Inc. discloses in a filing with the US Securities and Exchange Commission in New York on Aug 7th '26.
For institutional investors. Book with your work email.
Spatial Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Spatial Genomics's valuation, stock price, and market status.
Is Spatial Genomics a public or private company?
Spatial Genomics is a private company.
What is the current stock price of Spatial Genomics?
Spatial Genomics is a private company, so its shares have no public market price. Caplight tracks Spatial Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Spatial Genomics worth (valuation)?
Valuation information for Spatial Genomics is not publicly available.
Can I buy Spatial Genomics stock?
Spatial Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Spatial Genomics's last funding round?
Spatial Genomics's most recent funding round was Series A on February 23, 2022.
Who are the main investors in Spatial Genomics?
Key investors in Spatial Genomics include National Institute of Mental Health, National Cancer Institute, National Institute on Aging, Chan Zuckerberg Initiative, National Institute of General Medical Sciences.
Will Spatial Genomics IPO soon?
No public IPO plans have been announced for Spatial Genomics.
How can I track Spatial Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Spatial Genomics's shares on secondary markets.